Septic Shock: Clinical Trials

22 trials for Septic Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 unknown. 22 Phase 2, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 222Unknown 22
Phase 33Unknown 3
Phase 12Unknown 2

Follow Septic Shock: new trials by email Literature Review of Septic Shock trials Research Report on Septic Shock

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine and Vasopressin in Septic Shock
DEX-PRESSIN, Standard of Care - Sepsis, Septic Shock
Phase 2UnknownMansoura University2602024-06-012024-03-12
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
normal saline solution, Hydrocortisone and normal saline solution - Septic Shock, Adverse Event
Phase 2UnknownMahidol University1602023-07-052024-04-05
The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock
Ondansetron, Placebo - Sepsis, Septic Shock
Phase 1 / Phase 2UnknownNoha Mansour402022-04-242023-03-15
Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment
Treatment-specific InSight, InSight - Sepsis, Severe Sepsis
Phase 2UnknownDascena516452022-04-012021-09-23
Milrinone Versus Placebo in Patients With Septic Shock
Milrinone - Septic Shock, Cardiac Output
Phase 2UnknownMahidol University642021-12-012022-09-15
Machine Learning Sepsis Alert Notification Using Clinical Data
HindSight, InSight - Sepsis, Severe Sepsis
Phase 2UnknownDascena379862021-09-252022-05-03
Evaluation of Safety and Dosing of a Vitamin C Bundle for Sepsis Treatment in Africa
Vitamin C, Vitamin B1 - Sepsis, Septic Shock
Phase 2UnknownLiverpool School of Tropical Medicine602021-09-012021-09-08
Terlipressin for Refractory Septic Shock
Terlipressin, Placebo - Septic Shock, Refractory Shock
Phase 2UnknownMahidol University1302020-04-032021-09-24
VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients
VBI-S - Septic Shock, Sepsis
Phase 2UnknownVivacelle Bio202020-02-172023-10-23
Methylene Blue as a Third-line Vasopressor in Septic Shock
Methylene Blue, Phenylephrine - Septic Shock
Phase 2UnknownCarilion Clinic2502019-12-012022-07-26
Treatment of Severe Infection With Antihyperlipidemia Drug
Alirocumab Injectable Product, Saline Solution - Sepsis, Septic Shock
Phase 2 / Phase 3UnknownWolfson Medical Center7122019-01-012018-08-16
Shenfu Injection Improves Arterial Vascular Reactivity
shenfu injection - Septic Shock, Shenfu
Phase 2 / Phase 3UnknownJianfeng Xie262018-12-012018-11-21
A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock
LJPC-501 (angiotensin II), Placebo - Catecholamine-resistant Hypotension (CRH), Distributive Shock
Phase 2UnknownLa Jolla Pharmaceutical Company1002018-08-012018-08-09
Cellular Immunotherapy for Septic Shock
Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells, Placebo - Septic Shock, Sepsis
Phase 2UnknownOttawa Hospital Research Institute1142018-03-012017-12-11
Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2
Esmolol - Septic Shock
Phase 2UnknownSamuel Brown102017-08-072019-02-26
Short-course Antimicrobial Therapy in Sepsis
Antibiotic - Infection, Sepsis
Phase 2UnknownOspedale Santa Maria delle Croci3202016-09-012021-09-08
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Esmolol administration - Septic Shock
Phase 2UnknownAssistance Publique - Hôpitaux de Paris452015-04-012023-08-31
Esmolol Effects on Heart and Inflammation in Septic Shock
Esmolol - Septic Shock
Phase 2UnknownCentral Hospital, Nancy, France252013-12-012016-01-28
Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia
Mesenchymal stromal cells, Standard therapy of septic shock - Septic Shock, Nonchemotherapy Drug-induced Neutropenia
Phase 1 / Phase 2UnknownNational Research Center for Hematology, Russia302012-12-012013-05-10
Angiotensin in Septic Kidney Injury Trial
Angiotensin II, Saline placebo - Acute Renal Failure, Sepsis
Phase 2UnknownAustin Health122010-02-012011-06-23

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Shock, Septic (22)  ·  Sepsis (11)  ·  Shock (3)  ·  Infections (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Disease (1)  ·  Heart Failure (1)  ·  Hyperglycemia (1)  ·  Hypernatremia (1)  ·  Hypovolemia (1)  ·  Inflammation (1)  ·  Malnutrition (1)  ·  Muscle Weakness (1)  ·  Neutropenia (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (22)  ·  Inflammation (21)  ·  Pathologic Processes (21)  ·  Systemic Inflammatory Response Syndrome (21)  ·  Infections (20)  ·  Shock (19)  ·  Sepsis (11)  ·  Nutritional and Metabolic Diseases (2)  ·  Urogenital Diseases (2)  ·  Agranulocytosis (1)  ·  Blood-Borne Infections (1)  ·  Cardiovascular Diseases (1)  ·  Communicable Diseases (1)  ·  Cytopenia (1)  ·  Female Urogenital Diseases (1)

Interventions

esmolol (3)  ·  Angiotensin II (2)  ·  Saline Solution (2)  ·  Terlipressin (2)  ·  Angiotensin I (1)  ·  Anti-Bacterial Agents (1)  ·  Ascorbic Acid (1)  ·  Compact Disks (1)  ·  Control Groups (1)  ·  Dobutamine (1)  ·  Drug Delivery Systems (1)  ·  Hydrocortisone (1)  ·  Methylene Blue (1)  ·  Milrinone (1)  ·  Ondansetron (1)

Sponsors

Mahidol University (3)  ·  Dascena (2)  ·  Assaf-Harofeh Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Austin Health (1)  ·  Carilion Clinic (1)  ·  Central Hospital, Nancy, France (1)  ·  Jianfeng Xie (1)  ·  La Jolla Pharmaceutical Company (1)  ·  Liverpool School of Tropical Medicine (1)  ·  Mansoura University (1)  ·  National Research Center for Hematology, Russia (1)  ·  Noha Mansour (1)  ·  Ospedale Santa Maria delle Croci (1)  ·  Ottawa Hospital Research Institute (1)

Countries

United States (4)  ·  Thailand (3)  ·  Australia (2)  ·  France (2)  ·  Israel (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Russia (1)  ·  Uganda (1)

Top investigators

Antoine Kimmoun, MD (1)  ·  Bruno Levy, MD PhD (1)  ·  Cuthbert Simpkins, MD, FACS (1)  ·  Forbes McGain, MBBS FJFICM (1)  ·  Frank Biscardi (1)  ·  Gennady M. Galstyan, MD PhD (1)  ·  Jana Hoffman, PhD (1)  ·  Lauralyn McIntyre, MD (1)  ·  Michael C Reade, MBBS DPhil (1)  ·  Moataz M Emara (1)  ·  Qingqing Mao, PhD (1)  ·  Samuel M Brown, MD MS (1)  ·  Shevin T Jacob, MD MPH (1)  ·  Surat Tongyoo (1)

Results publications

PMID 26903338, PMID 28101605, PMID 30704260, PMID 33413583, PMID 38545092, PMID 40138463

NIH funding

R44AA030000 (1)